News
Latin America Solution For Disrupted Clinical Trials Due To The Conflict In Ukraine
A database of privately and publicly funded clinical studies conducted around the world from 220 countries shows that there are 5,934 registered clinical studies in the Russian Federation and over 2,400 in Ukraine, not to mention over 300 in Belarus.
Farmacon global announces partnership with validcare for nimble clinical trials
“Through our partnership with Validcare we can offer the empir- ical results of more facile connections with our trial participants through e-CRF, e-diaries and more
Farmacon global corporate social responsability plan to benefit rare disease patients.
“During this season of giving, Farmacon Global is pleased to announce LINK, our 2022 corporate social responsibility pro gram,” said Sara Tylosky, CEO Farmacon Global.
Farmacon Global Newsbrief August 23
“We are not just talking about Biopharma Industries’ possibilities in these emerging markets,” said Sara Tylosky, CEO Farmacon Global. “It’s also about opportunities for patients
A Leadership Role in Latin America
Rare Disease patients are the key to new treatment development, and Latin America is no exception. On July 14th, 2021, Farmacon Global implemented another successful
Save the Date for Farmacon Global and USC San Diego Extension’s Rare Disease Assembly, September 9th, 2021.
“This year our Rare Disease Assembly, called ‘Rare Diem – Seizing Opportunities for Rare Diseases in EmergingMarkets’ will be virtual,” said Sara Tylosky, CEO, Farmacon